BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29093402)

  • 1. Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.
    Nakamura Y; Nakajima H; Hosokawa T; Yamane K; Ishida S; Kimura F
    Intern Med; 2018 Jan; 57(2):269-271. PubMed ID: 29093402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ataxia and ophthalmoplegia: an atypical case of Miller Fisher syndrome (MFS) with anti-GAD antibody.
    Shoraka AR; Fang X; Hamouda D; Gogia B; Li X
    Int J Neurosci; 2022 Oct; 132(10):994-998. PubMed ID: 33280463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies.
    Muñiz-Castrillo S; Vogrig A; Joubert B; Pinto AL; Gonçalves D; Chaumont H; Rogemond V; Picard G; Fabien N; Honnorat J
    Cerebellum; 2020 Oct; 19(5):715-721. PubMed ID: 32592031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Miller Fisher Syndrome with Cerebellar Hypoperfusion.
    Sumi K; Kimura N; Watanabe Y; Yabuuchi K; Matsubara E
    Tohoku J Exp Med; 2023 May; 260(1):47-50. PubMed ID: 36889739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
    Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
    Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-glutamic acid decarboxylase antibody positive neurological syndromes.
    Tohid H
    Neurosciences (Riyadh); 2016 Jul; 21(3):215-22. PubMed ID: 27356651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ataxia with ophthalmoplegia: Miller-Fisher syndrome with anti-GQ1b antibody positivity].
    Guilloton L; Camarasa C; Agard E; Tondeur G; Dot C; Drouet A
    J Fr Ophtalmol; 2014 Feb; 37(2):89-92. PubMed ID: 24513384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
    Bonnan M; Cabre P; Olindo S; Signate A; Saint-Vil M; Smadja D
    Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miller Fisher syndrome with positivity of anti-GAD antibodies.
    Pietrini V; Pavesi G; Andreetta F
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1479-81. PubMed ID: 23253818
    [No Abstract]   [Full Text] [Related]  

  • 13. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
    Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
    J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlap of Myasthenia Gravis and Miller Fisher Syndrome.
    Tanaka Y; Satomi K
    Intern Med; 2016; 55(14):1917-8. PubMed ID: 27432103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miller Fisher syndrome mimicking ocular myasthenia gravis.
    Anthony SA; Thurtell MJ; Leigh RJ
    Optom Vis Sci; 2012 Dec; 89(12):e118-23. PubMed ID: 23190719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
    Vianello M; Tavolato B; Armani M; Giometto B
    Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Planche V; Marques A; Ulla M; Ruivard M; Durif F
    Cerebellum; 2014 Jun; 13(3):318-22. PubMed ID: 24218114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.
    Georgieva Z; Parton M
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The detection of anti-cerebellar antibody western blot analysis in serum from a patient with Miller Fisher syndrome].
    Iwahashi T; Inoue A; Koh S; Yanagihara N
    Arerugi; 1995 Sep; 44(9):1176-80. PubMed ID: 8534214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.